@GiannakisLab
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Associate Professor of Medicine | @DanaFarber @broadinstitute @harvardmed | Views mine
Joined May 2019
- Tweets13
- Following6
- Followers251
- Likes0
Marios Giannakis retweeted
Dr. Kimmie Ng says researchers are evaluating a range of factors that could be fueling a rise in colon cancer, everything from a lack of vitamin D, to the complicated role of the microbiome.
CC: @KimmieNgMD @DFarberYoungCRC @NPR
npr.org/sections/health-shot…
Marios Giannakis retweeted
1/4 New Perspectives piece from Marios Giannakis and @KimmieNgMD of team OPTIMISTICC in @ScienceMagazine discusses the rising global incidence of early-onset colorectal cancer (EOCRC) science.org/doi/10.1126/scie…
Marios Giannakis retweeted
I’m on the @ScienceMagazine weekly podcast to talk about the Perspective piece that @GiannakisLab and I wrote on #YoungOnsetColorectalCancer. Tune in to the conversation by clicking below! @DFarberYoungCRC @DanaFarber @DanaFarberNews
On this week's #SciencePodcast🎙️ with @boron110, @KimmieNgMD, and @voooos:
▶️ An active volcano on Venus
▶️ A concerning rise in early onset colon cancer
🎧 Listen here: scim.ag/1UY
Marios Giannakis retweeted
Must-read perspective by @GiannakisLab & @KimmieNgMD on the ongoing epidemic of early-onset colorectal cancer diagnoses. Reasons likely complex/multi factorial, in need of deep investigation in order to revert this concerning phenomenon.
science.org/doi/10.1126/scie…
Why are so many young people getting colon cancer?
science.org/doi/10.1126/scie…
@ScienceMagazine w/ @ScienceVisuals by @GiannakisLab @KimmieNgMD @DFarberYoungCRC @DanaFarber
Marios Giannakis retweeted
Young-onset #ColorectalCancer: A common cancer at an uncommon age. Publishing online in @ScienceMagazine, @DanaFarber's @KimmieNgMD and @GiannakisLab chart a course to better understand, prevent, and treat the disease.
Read: bit.ly/3mTGtFP
CC: @DFarberYoungCRC
Marios Giannakis retweeted
Read more in the @ASCOPost on research into the effectiveness of a molecular tumor board in precision oncology for patients with gastrointestinal cancer treated at the Dana-Farber Brigham Cancer Center.
CC: @DFarberYoungCRC @GiannakisLab
Read more ➡️ bit.ly/3CYAg0r
Marios Giannakis retweeted
New #ColorectalCancer research from #AACRcrc22 shows an oncogenic role and therapeutic options for one of the most frequent colorectal cancer mutations: RNF43 G659fs. Research presented by Dana-Farber's Marios Giannakis, MD, PhD (@GiannakisLab)
Excited to share our latest research showing an oncogenic role and therapeutic options for one of the most frequent Colorectal Cancer mutations @GiannakisLab @DanaFarber @broadinstitute
nature.com/articles/s41467-0…
Marios Giannakis retweeted
We are excited to share our study on spatially organized multicellular immune hubs in human colorectal cancer cell.com/cell/fulltext/S0092… @CellCellPress. Joint effort with @karin_pelka, @chenchirps, @AnaAndersonlab, Orit Rozenblatt-Rosen, Aviv Regev, Nir Hacohen, many others!
Marios Giannakis retweeted
Red meat and cancer 🥩 New research led by Dana-Farber's Marios Giannakis, MD, PhD, finds high red meat consumption may promote DNA damage-associated mutations in patients with #colorectalcancer, published in @CD_AACR: ms.spr.ly/6015nHLrx cc @DFarberYoungCRC
Colorectal cancer awareness month at the Dana-Farber Cancer Institute @DFarberYoungCRC
Marios Giannakis retweeted
New research in @NatureComms: Resistance to immune checkpoint blocker drug linked to metabolic imbalance ms.spr.ly/6015TuH5P #KidneyCancer #Melanoma @DrChoueiri @GiannakisLab
Our work on immune-checkpoint inhibitor resistance in mismatch-repair deficient cancers may offer clues to new immunotherapy strategies in colorectal cancer
cancerimmunolres.aacrjournal…